ArticleQuantitative imaging in medicine and surgery2025
Percentage apparent diffusion coefficient change for early prediction of response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis, and a retrospective study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparison of [European journal of nuclear medicine and molecular imaging · 2026Article
- Diagnostic Accuracy of Post-Treatment ADC and MRI Response Assessment for Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.Journal of clinical medicine · 2026Article
- Multiparametric MRI and artificial intelligence for non-invasive HER2 assessment in breast cancer: a comprehensive review.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neoadjuvant chemotherapy (NACT) is an important part of comprehensive breast cancer treatment. However, considering that not all patients respond well, how to identify responders as soon as possible is a significant issue. Magnetic resonance imaging (MRI) shows excellent diagnostic accuracy in breast cancer, while whether it is able to identify NACT responders is not clear. In this study, we aim to evaluate the role of early percentage apparent diffusion coefficient change (ΔADC%) in predicting response to NACT in patients with breast cancer. Methods: We searched studies in PubMed, Web of Science, and Cochrane Library up to April 28, 2025. The inclusion criteria were: predicting response to NACT in breast cancer; using ΔADC% as prediction parameter; diffusion-weighted imaging (DWI)-MRI images were acquired before NACT beginning and early during NACT (after 1 or 2 cycles); providing exact criteria for responders. The exclusion criteria were: not in English or Chinese; animal studies; review/meta-analysis/abstract/case report; the number of true-positive (TP), false-negative (FN), false-positive (FP), and true-negative (TN) findings cannot be extracted directly or indirectly. The methodological quality of the included studies was assessed by Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2. Sensitivity, specificity, and summary receiver operating characteristic (SROC) curve were used to evaluate the prediction accuracy. Sub-group analyses were used to find the source of heterogeneity. For the retrospective study, 47 patients with breast cancer from our hospital were included. We used the Mann-Whitney Results: In the meta-analysis, 11 studies and 681 patients were included. Pooled sensitivity and specificity were 0.71 [95% confidence interval (CI): 0.60-0.79] and 0.78 (95% CI: 0.68-0.85), respectively. AUC was 0.81 (95% CI: 0.77-0.84). There was no obvious difference between the sub-groups. In the validation study, ΔADC% was significantly higher in the pCR group than in the non-pCR group. When 20.3% was chosen as the cut-off value, ΔADC% had a sensitivity of 64.7% and a specificity of 73.3% in predicting pCR. Conclusions: ΔADC% may be valuable in early prediction of response to NACT in breast cancer. The results need further validation in a larger population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.